Health2 months ago
Novavax Expands License for Sanofi’s Pandemic Flu Vaccine Development
Novavax has expanded its licensing agreement with Sanofi, allowing the French pharmaceutical company to utilize its Matrix-M adjuvant in the development of a pandemic influenza vaccine....
